Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age–sex interaction and spatial–temporal variability

References

• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267:944–53.
   PubMed Web of Science ®Google Scholar
• Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J. Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci. 2019;20:2616.
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet. 1993;1:3–18.
   PubMed Web of Science ®Google Scholar
• Muroni A, Murru MR, Sechi M, Ercoli T, Marrosu F, Bentivoglio AR, et al. Prevalence of Huntington's disease in Southern Sardinia, Italy. Parkinson Relat Disord. 2020;80:54–7.
   PubMed Web of Science ®Google Scholar
• Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882.e7–2882.e12.
   PubMed Web of Science ®Google Scholar
• Orrù S, Manolakos E, Orrù N, Kokotas H, Mascia V, Carcassi C, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172–8.
   PubMed Web of Science ®Google Scholar
• ISTAT; 2021. Available at: www.istat.it
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Eurostat report; 2013. Available at: https://ec.europa.eu/eurostat/documents/3859598/5926869/KS-RA-13-028-EN.PDF/e713fa79-1add-44e8-b23d-5e8fa09b3f8f
   Google Scholar
• Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
   PubMed Web of Science ®Google Scholar
• Defazio G, Ercoli T, Erro R, Pellicciari R, Mascia MM, Fabbrini G, et al. Idiopathic non-task-specific upper limb dystonia, a neglected form of dystonia. Mov Disord. 2020;35:2038–45.
   PubMedGoogle Scholar
• Tinazzi M, Geroin C, Marcuzzo E, Cuoco S, Ceravolo R, Mazzucchi S, et al. Functional motor phenotypes: to lump or to split? J Neurol. 2021;268:4737–43.
   PubMed Web of Science ®Google Scholar
• Sahai H, Khurshid A. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med. 1996;15:1–21.
   PubMed Web of Science ®Google Scholar
• Szklo M, Nieto FJ. Epidemiology: beyond the basics. 4th ed.; 2018. Jones & Bartlett Learning, 5 Wall Street Burlington, MA 01803
   Google Scholar
• Pugliatti M, Parish LD, Cossu P, Leoni S, Ticca A, Saddi MV, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009. J Neurol. 2013;260:572–9.
   PubMed Web of Science ®Google Scholar
• Chiò A, Moglia C, Canosa A, Manera U, D'Ovidio F, Vasta R, et al. ALS phenotype is influenced by age, sex, and genetics. Neurology. 2020;94:e802–e10.
   PubMed Web of Science ®Google Scholar
• Raymond J, Mehta P, Larson T, Pioro EP, Horton DK. Reproductive history and age of onset for women diagnosed with amyotrophic lateral sclerosis: data from the National ALS Registry: 2010–2018. Neuroepidemiology. 2021;55:416–24.
   PubMed Web of Science ®Google Scholar
• Boumediene F, Vasta R, Rascunà C, Lo Fermo S, Volanti P, Marziolo R, et al. Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy. Eur J Neurol. 2019;26:e90–e1.
   PubMed Web of Science ®Google Scholar
• Vasta R, Calvo A, Moglia C, Cammarosano S, Manera U, Canosa A, et al. Spatial epidemiology of amyotrophic lateral sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis. Eur J Neurol. 2018;25:756–61.
   PubMed Web of Science ®Google Scholar
• Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990;47:38–41.
   PubMedGoogle Scholar
• Sabel CE, Boyle PJ, Löytönen M, Gatrell AC, Jokelainen M, Flowerdew R, et al. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol. 2003;157:898–905.
   PubMed Web of Science ®Google Scholar
• Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler. 2009;10:101–8.
   PubMed Web of Science ®Google Scholar
• Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, Ampong M-A, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009;32:81–8.
   PubMed Web of Science ®Google Scholar
• Masseret E, Banack S, Boumédiène F, Abadie E, Brient L, Pernet F, et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France. PLOS One. 2013;8:e83406.
   PubMed Web of Science ®Google Scholar
• Rooney J, Vajda A, Heverin M, Elamin M, Crampsie A, McLaughlin R, et al. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 2015;84:1537–44.
   PubMed Web of Science ®Google Scholar
• Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 2009–2011. Am J Epidemiol. 2015;182:512–9.
   PubMed Web of Science ®Google Scholar
• Spencer PS, Lagrange E, Camu W. ALS and environment: clues from spatial clustering? Rev Neurol. 2019;175:652–63.
   PubMedGoogle Scholar
• Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. TBK1 is associated with ALS and ALS-FTD in Sardinian patients. Neurobiol Aging. 2016;43:e1–e5.
   PubMed Web of Science ®Google Scholar
• Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. Neurobiol Aging. 2015;36:2906.e1–2906.e5.
   Web of Science ®Google Scholar